# Nature Reviews Drug Discovery

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/nature-reviews-drug-discovery/

## Facts

| Field | Value |
| --- | --- |
| Citations | 782,363 |
| h-index | 476 |
| Homepage | https://www.nature.com/nrd/ |
| Open Access | false |
| ISSN-L | 1474-1776 |
| ISSNs | 1474-1776,1474-1784 |
| OpenAlex ID | https://openalex.org/S186543748 |
| Publisher | Nature Portfolio |
| Works | 6,869 |

## Journal papers

- [Natural products in drug discovery: advances and opportunities](https://scholariq.org/papers/natural-products-in-drug-discovery-advances-and-opportunities/)
- [Radiopharmaceutical therapy in cancer: clinical advances and challenges](https://scholariq.org/papers/radiopharmaceutical-therapy-in-cancer-clinical-advances-and-challenges/)
- [Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives](https://scholariq.org/papers/biomarkers-for-alzheimer-s-disease-academic-industry-and-regulatory-perspectives/)
- [Complement, a target for therapy in inflammatory and degenerative diseases](https://scholariq.org/papers/complement-a-target-for-therapy-in-inflammatory-and-degenerative-diseases/)
- [Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome](https://scholariq.org/papers/drug-development-for-neurodevelopmental-disorders-lessons-learned-from-fragile-x/)
- [Drug repositioning for Alzheimer's disease](https://scholariq.org/papers/drug-repositioning-for-alzheimer-s-disease/)
- [NAAG peptidase inhibitors and their potential for diagnosis and therapy](https://scholariq.org/papers/naag-peptidase-inhibitors-and-their-potential-for-diagnosis-and-therapy/)
- [Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers](https://scholariq.org/papers/relative-efficacy-of-drugs-an-emerging-issue-between-regulatory-agencies-and/)

## Journal top topics

Showing 8 of 25.

- [Science, Research, and Medicine](https://scholariq.org/topics/science-research-and-medicine/)
- [Biotechnology and Related Fields](https://scholariq.org/topics/biotechnology-and-related-fields/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Biomedical Ethics and Regulation](https://scholariq.org/topics/biomedical-ethics-and-regulation/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.